Question

A 52-year-old postmenopausal woman is placed on a drug that decreases osteoclast activation but may intensify hot flashes. Which drug was most likely given to this patient? (A) alendronate (B) strontium ranelate (C) calcitonin (D) raloxifene (E) teriparatide

   A 52-year-old postmenopausal woman is placed on a drug that decreases osteoclast activation but may intensify hot flashes. Which drug was most likely given to this patient?
(A) alendronate
(B) strontium ranelate
(C) calcitonin
(D) raloxifene
(E) teriparatide
Show more…
Pharmacology
Pharmacology
George M. Brenner,… 4th Edition
Chapter 36, Problem 1 ↓

Instant Answer

verified

Step 1

This means that it inhibits the activity of osteoclasts, which are cells responsible for breaking down bone tissue. This suggests that the drug is likely an anti-resorptive agent, meaning it helps to prevent bone loss.  Show more…

Show all steps

lock
AceChat toggle button
Close icon
Ace pointing down

Please give Ace some feedback

Your feedback will help us improve your experience

Thumb up icon Thumb down icon
Thanks for your feedback!
Profile picture
A 52-year-old postmenopausal woman is placed on a drug that decreases osteoclast activation but may intensify hot flashes. Which drug was most likely given to this patient? (A) alendronate (B) strontium ranelate (C) calcitonin (D) raloxifene (E) teriparatide
Close icon
Play audio
Feedback
Powered by NumerAI
*

Labs

-

Want to see this concept in action?

NEW

Explore this concept interactively to see how it behaves as you change inputs.

View Labs

*

Key Concepts

-
Selective Estrogen Receptor Modulators (SERMs)
SERMs are a class of drugs that interact with estrogen receptors to provide tissue-specific effects. In bone, they mimic estrogen to decrease bone resorption by inhibiting osteoclast activity, which is beneficial in conditions like osteoporosis. However, in other tissues, such as the hypothalamus, they can act as estrogen antagonists, leading to side effects such as intensified hot flashes.
Osteoclast Activity and Bone Remodeling
Osteoclasts are specialized cells responsible for breaking down bone tissue, a process known as bone resorption. Proper bone remodeling requires a balance between osteoclast-mediated resorption and osteoblast-mediated formation. In postmenopausal osteoporosis, increased osteoclast activity leads to bone loss, making the inhibition of these cells a crucial therapeutic target.

*

Recommended Videos

-
48_-which-ofthe-following-hormones-prescribed-asa-medication-would-be-expected-to-help-elderly-folks-maintain-healthy-strong-bones-a_-pth-b-epinephrine-c-calcitonin-d_-cortisol-04966

Which of the following hormones (prescribed as a medication) would be expected to help elderly folks maintain healthy strong bones? A. PTH B Epinephrine C Calcitonin D. Cortisol

Need help? Use Ace
Ace is your personal tutor. It breaks down any question with clear steps so you can learn.
Start Using Ace
Ace is your personal tutor for learning
Step-by-step explanations
Instant summaries
Summarize YouTube videos
Understand textbook images or PDFs
Study tools like quizzes and flashcards
Listen to your notes as a podcast
Continue solving this problem
Create a free account to:
  • View full step-by-step solution
  • Ask follow-up questions with Ace AI
  • Save progress and study later
Continue Free
Numerade

Get step-by-step video solution
from top educators

Continue with Clever
or



By creating an account, you agree to the Terms of Service and Privacy Policy
Already have an account? Log In

A free answer
just for you

Watch the video solution with this free unlock.

Numerade

Log in to watch this video
...and 100,000,000 more!


EMAIL

PASSWORD

OR
Continue with Clever